4.5 Article

A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis

Journal

JOURNAL OF MEDICAL GENETICS
Volume 48, Issue 4, Pages 219-225

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jmg.2009.074567

Keywords

-

Funding

  1. Instituto de Salud Carlos III, FIS [PI070517, PI080151]
  2. Junta de Castilla y Leon, Spain [GR75/08, SA033A08, SA03508, SA036A08]
  3. Ministerio de Ciencia y Tecnologia, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Spain [BFU2006-12577, SAF2009-08493]
  4. Fundacion Investigacion Medica, Mutua Madrilena, Spain
  5. Ministerio de Educacion y Ciencia, Spain and the European Regional Development Fund (ERDF) [BFU2007-30688-E/BFI]
  6. Instituto de Salud Carlos III, Spain
  7. Ministerio de Educacion, Spain [AP2008-03762]

Ask authors/readers for more resources

Background Green jaundice is a rare finding usually associated with end-stage liver disease. Objective The authors investigated two unrelated Inuit women from different geographical areas in Greenland who had episodes of green jaundice associated with biliary obstruction. Methods and results The crises were accompanied by increased biochemical markers of cholestasis, together with absent or moderate hyperbilirubinaemia. In contrast, high-performance liquid chromatography tandem mass spectrometry showed hypercholanaemia and high concentrations of biliverdin IX alpha in serum, urine, bile and milk. Hyperbiliverdinaemia disappeared after surgical correction of the cholestasis. Analysis of the coding sequence of the biliverdin reductase alpha (BVR alpha) gene (BLVRA) detected three single-nucleotide polymorphisms: c.90G -> A, c.214C -> A and c.743A -> C, which result in p.Ala3Thr, p.Ser44X and p.Gly220Gly, respectively. With the use of TaqMan probes, homozygosity for c.214C -> A was found in both patients. Both parents of one of these patients were heterozygous for the inactivating mutation. Her brother was homozygous for normal alleles. Although her sister was also homozygous for the c.214C -> A mutation, she had never had hyperbiliverdinaemia or cholestasis. With the use of human liver RNA, the BVRa coding sequence was cloned, and the variant containing c.214C -> A was generated by site-directed mutagenesis. Both proteins were expressed in human hepatoma liver cells and Xenopus laevis oocytes. Immunoblotting, immunofluorescence and functional assays of BVR alpha activity revealed that the mutated sequence generates a truncated protein with no catalytic activity. Conclusion This is the first report of a homozygous BLVRA inactivating mutation indicating that the complete absence of BVR alpha activity is a non-lethal condition, the most evident phenotypic characteristic of which is the appearance of green jaundice accompanying cholestasis episodes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available